Tursi James Patrick
SEC-identified person · CIK 1527710 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Neurobo Pharmaceuticals, Inc. NRBO | Director | filed 2023 - 2026 |
| Endo International plc ENDP | Executive VP, Global R&D | filed 2022 - 2022 |
| Agile Therapeutics INC AGRX | Director | filed 2014 - 2022 |
| Antares Pharma, INC. ATRS | EVP, Chief Medical Officer | filed 2018 - 2019 |
| Aralez Pharmaceuticals Inc. ARLZ | Chief Medical Officer | filed 2016 - 2018 |
| Pozen INC /NC POZN | Chief Medical Officer | filed 2015 - 2015 |
| Auxilium Pharmaceuticals INC AUXL | Chief Medical Officer | filed 2011 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.